Acetamide, N-[4-[4-(4-fluorophenyl)-1-methyl-2-(methylsulfinyl)-1H-imidazol-5-yl]-2-pyridinyl]- manufacturers
- CBS-3595
-
- $1670.00
-
2026-07-27
- CAS:908380-97-2
- Purity:
- Supply Ability: 10g
|
| | Acetamide, N-[4-[4-(4-fluorophenyl)-1-methyl-2-(methylsulfinyl)-1H-imidazol-5-yl]-2-pyridinyl]- Basic information |
| | Acetamide, N-[4-[4-(4-fluorophenyl)-1-methyl-2-(methylsulfinyl)-1H-imidazol-5-yl]-2-pyridinyl]- Chemical Properties |
| density | 1.38±0.1 g/cm3(Predicted) | | pka | 13.51±0.70(Predicted) |
| | Acetamide, N-[4-[4-(4-fluorophenyl)-1-methyl-2-(methylsulfinyl)-1H-imidazol-5-yl]-2-pyridinyl]- Usage And Synthesis |
| Uses | CBS-3595 is a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 with anti-inflammatory and anti-allodynic activities. CBS-3595 reduces the production of the proinflammatory cytokine IL-6 and increases the levels of the anti-inflammatory cytokine IL-10 in rats. CBS-3595 reduces paw oedema formation in the Complete Freund’s adjuvant (CFA) (HY-153808)-induced arthritis rat model. CBS-3595 is promising for research of autoimmune diseases[1]. | | References | [1] Koch DA, et al. Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats. Rheumatology (Oxford). 2014 Mar;53(3):425-32. DOI:10.1093/rheumatology/ket369 |
| | Acetamide, N-[4-[4-(4-fluorophenyl)-1-methyl-2-(methylsulfinyl)-1H-imidazol-5-yl]-2-pyridinyl]- Preparation Products And Raw materials |
|